In contrast, Tan et al. connected SIRT1 overexpression with shorter survival in luminal cancers [147], while Wu et al. linked it with cancer progression and dismal prognosis in both TNBCs and non-TNBCs [148]. This evidence concerns the gene SIRT1 and cancer.